Ads
related to: bristol-myers- Careers
Join our Mission to Improve
the Lives of Patients.
- About Us
Discover the Unique Approach
That Makes Genmab Different.
- Pipeline
Review our Pipeline and
See How We're Changing Treatment.
- Sign Up
Sign Up for Updates, News
and Much More.
- Approved Medicines
See the Approved Treatments
Using Our Antibody Science.
- Antibody Science
Explore Our Unique Platforms
For Creating Antibody Treatments.
- Careers
scbn.org has been visited by 10K+ users in the past month
Search results
Biotech Slumps Despite 'Pristine' Results For Bristol-Rivaling Heart Drug
Investor's Business Daily· 2 days agoThe company tested its drug, aficamten, in patients with obstructive hypertrophic cardiomyopathy, or...
Health Care Flat as Traders Digest Earnings Data - Health Care Roundup
Market Watch· 2 days agoJoyce, president of financial advisory Joyce Wealth Management. First-quarter earnings contracted by 25% from a year earlier for the health-care industry group, but the majority of that reflected ...
Merck stopped a clinical trial for its experimental skin cancer drug after a high rate of side...
Quartz· 2 days agoMerck announced Monday that it is pulling the plug on its phase 3 trial of an experimental...
Getting In on This “Macro-Trend”
InvestorPlace via Yahoo Finance· 7 days agoHello, Reader. Wall Street has sold investors on the idea that they should start with “micro” analysis. That’s the idea that they should make investment decisions by comparing things like price ...
BMS and Zai Lab’s Augtyro gains NMPA approval to treat NSCLC
Pharmaceutical Technology via Yahoo Finance· 2 days agoZai Lab has an exclusive license to develop and commercialise the therapy in Greater China. The...
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 5% Dividend Yields -...
Benzinga· 5 days agoThis analyst has an accuracy rate of 70%. Recent News: Organon announced pricing of $1.0 billion...
What's Going On With Medical Therapeutic Firm Aethlon Medical On Friday? - Aethlon Medical...
Benzinga· 5 days ago“The positive data from this in vitro binding study of the Hemopurifier is an important step forward...
This company has been the biggest drag on the S&P 500’s results this quarter
Market Watch· 3 days agoHigher prices for groceries, which make up a majority of Walmart’s sales, have helped, even as...
Prothena (PRTA) Q1 Earnings Miss Estimates on Higher R&D Expenses
Zacks· 7 days agoFree Report) reported a loss of $1.34 per share in first-quarter 2024, wider than the Zacks...
2seventy bio Inc (TSVT) Q1 2024 Earnings Call Transcript Highlights: Strategic Shifts and ...
GuruFocus.com via Yahoo Finance· 6 days agoRevenue: Acme U.S. revenues reported by Bristol-Myers Squibb for $52 million. Net Income: Share of collaboration loss of $1.2 million related to collaboration with BMS. Cost ...